Spectral Medical(EDTXF)
$0.80+0.06 (+7.84%)
EDTXF
Spectral Medical financials statements
$0.80
At close:+0.06 (+7.84%)
Spectral Medical (EDTXF) Ratios
21 Followers
Spectral Medical Ratios
EDTXF's free cash flow for Q2 2026 was C$-2.06M. For the 2026 fiscal year, EDTXF's free cash flow was increased by C$0.00 and operating cash flow was C$-2.06M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.08 | 0.16 | 0.40 | 1.52 | 4.46 |
| Quick Ratio | 0.07 | 0.15 | 0.37 | 1.47 | 4.33 |
| Cash Ratio | 0.06 | 0.11 | 0.29 | 1.27 | 3.86 |
| Solvency Ratio | -0.63 | -0.46 | -0.71 | -0.76 | -1.14 |
| Operating Cash Flow Ratio | -0.14 | -0.32 | -1.05 | -1.49 | -3.78 |
| Short-Term Operating Cash Flow Coverage | -0.58 | -0.61 | -40.61 | -2.78 | 0.00 |
| Net Current Asset Value | C$ -70.53M | C$ -28.41M | C$ -17.64M | C$ -4.46M | C$ 2.79M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 3.46 | 2.81 | 1.64 | 0.63 | 0.05 |
| Debt-to-Equity Ratio | -0.30 | -0.54 | -0.52 | -2.96 | 0.14 |
| Debt-to-Capital Ratio | -0.43 | -1.18 | -1.07 | 1.51 | 0.12 |
| Long-Term Debt-to-Capital Ratio | -0.07 | 0.00 | -0.87 | 3.74 | 0.00 |
| Financial Leverage Ratio | -0.09 | -0.19 | -0.31 | -4.70 | 2.83 |
| Debt Service Coverage Ratio | -1.96 | -0.68 | -8.73 | -1.92 | -227.68 |
| Interest Coverage Ratio | -2.26 | -3.78 | -8.56 | -47.99 | -237.75 |
| Debt to Market Cap | 0.05 | 0.10 | 0.07 | 0.07 | 0.00 |
| Interest Debt Per Share | 0.09 | 0.06 | 0.04 | 0.03 | 0.00 |
| Net Debt to EBITDA | -0.40 | -1.00 | -0.40 | 0.12 | 1.30 |
| Profitability Margins | |||||
| Gross Profit Margin | -211.14% | 44.53% | 41.43% | 58.97% | 58.32% |
| EBIT Margin | -1741.40% | -534.47% | -886.92% | -447.03% | -334.12% |
| EBITDA Margin | -1731.16% | -523.49% | -873.28% | -430.71% | -319.39% |
| Operating Profit Margin | -478.50% | -524.80% | -714.71% | -506.72% | -333.52% |
| Pretax Profit Margin | -1952.87% | -673.45% | -970.40% | -457.59% | -348.65% |
| Net Profit Margin | -1952.99% | -673.75% | -980.10% | -676.72% | -440.13% |
| Continuous Operations Profit Margin | -1952.87% | -673.45% | -970.40% | -457.59% | -348.65% |
| Net Income Per EBT | 100.01% | 100.05% | 101.00% | 147.89% | 126.24% |
| EBT Per EBIT | 408.12% | 128.32% | 135.78% | 90.30% | 104.54% |
| Return on Assets (ROA) | -781.84% | -289.51% | -300.56% | -94.04% | -76.03% |
| Return on Equity (ROE) | 68.40% | 55.92% | 94.64% | 441.70% | -215.16% |
| Return on Capital Employed (ROCE) | 19.42% | 54.22% | 227.01% | -157.48% | -71.95% |
| Return on Invested Capital (ROIC) | 26.80% | 158.46% | 245.82% | -93.59% | -71.24% |
| Return on Tangible Assets | -826.98% | -299.36% | -312.12% | -95.72% | -77.56% |
| Earnings Yield | -11.53% | -10.96% | -13.23% | -11.30% | -15.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.91 | 5.07 | 8.59 | 1.58 | 9.74 |
| Payables Turnover | 5.68 | 1.28 | 0.59 | 0.41 | 1.87 |
| Inventory Turnover | 20.15 | 5.54 | 2.56 | 2.01 | 2.84 |
| Fixed Asset Turnover | 5.15 | 3.33 | 1.79 | 2.38 | 1.88 |
| Asset Turnover | 0.40 | 0.43 | 0.31 | 0.14 | 0.17 |
| Working Capital Turnover Ratio | -0.06 | -0.16 | -1.20 | 0.29 | 0.34 |
| Cash Conversion Cycle | -15.52 | -147.05 | -437.16 | -467.83 | -28.76 |
| Days of Sales Outstanding | 30.64 | 72.01 | 42.48 | 231.22 | 37.49 |
| Days of Inventory Outstanding | 18.11 | 65.92 | 142.72 | 181.43 | 128.54 |
| Days of Payables Outstanding | 64.28 | 284.98 | 622.37 | 880.48 | 194.78 |
| Operating Cycle | 48.75 | 137.93 | 185.21 | 412.65 | 166.03 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.03 | -0.04 | -0.04 | -0.03 |
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 |
| Dividend Paid and CapEx Coverage Ratio | -48.84 | -326.59 | -57.95 | -300.00 | -18.01 |
| Capital Expenditure Coverage Ratio | -48.84 | -326.59 | -57.95 | -300.00 | -18.01 |
| Operating Cash Flow Coverage Ratio | -0.45 | -0.59 | -1.25 | -1.31 | -14.95 |
| Operating Cash Flow to Sales Ratio | -3.90 | -3.86 | -6.71 | -5.94 | -4.36 |
| Free Cash Flow Yield | -2.35% | -6.29% | -9.21% | -9.95% | -16.54% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.47 | -9.12 | -7.56 | -8.85 | -6.32 |
| Price-to-Sales (P/S) Ratio | 169.36 | 61.48 | 74.09 | 59.89 | 27.83 |
| Price-to-Book (P/B) Ratio | -5.93 | -5.10 | -7.15 | -39.09 | 13.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -42.55 | -15.89 | -10.86 | -10.05 | -6.05 |
| Price-to-Operating Cash Flow Ratio | -43.42 | -15.94 | -11.04 | -10.09 | -6.38 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | 3.66 | -0.22 | -0.41 | 0.60 |
| Enterprise Value Multiple | -10.19 | -12.74 | -8.89 | -13.79 | -7.41 |
| Enterprise Value | 430.60M | 152.48M | 124.00M | 99.00M | 47.23M |
| EV to EBITDA | -10.19 | -12.74 | -8.89 | -13.79 | -7.41 |
| EV to Sales | 176.33 | 66.70 | 77.60 | 59.39 | 23.66 |
| EV to Free Cash Flow | -44.30 | -17.24 | -11.37 | -9.97 | -5.14 |
| EV to Operating Cash Flow | -45.21 | -17.29 | -11.57 | -10.00 | -5.43 |
| Tangible Book Value Per Share | -0.24 | -0.10 | -0.06 | -0.01 | 0.02 |
| Shareholders’ Equity Per Share | -0.24 | -0.10 | -0.06 | -0.01 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Income Per Share | -0.17 | -0.05 | -0.06 | -0.04 | -0.03 |
| Tax Burden | 1.00 | 1.00 | 1.01 | 1.48 | 1.26 |
| Interest Burden | 1.12 | 1.26 | 1.09 | 1.02 | 1.04 |
| Research & Development to Revenue | 1.77 | 1.74 | 2.93 | 0.00 | 0.00 |
| SG&A to Revenue | 4.80 | 5.08 | 3.02 | 1.59 | 1.01 |
| Stock-Based Compensation to Revenue | 0.87 | 0.73 | 0.93 | 0.72 | 0.63 |
| Income Quality | 0.20 | 0.57 | 0.68 | 0.88 | 0.99 |
Currency in CAD
